Nutradina™Investors
Request briefing
Pre-launch · Formulation stage

Food engineered for the response it triggers.

Nutradina is a signal-based nutrition platform built by GiNOVA Engineering and GiNOVA Academy. The science is in place, the first lines are in formulation, and we are now opening conversations with investors and strategic partners, large or small.

Request the investor briefingReceive quarterly investor updates
Built by
GiNOVAEngineeringGiNOVAAcademy
3
scientific papers in the research program (theory, method, governance)
13
projects in the pipeline, consumer and professional
7
product families
$596B
global functional food market projected for 2033 Source: Straits Research, 2025. Other forecasts: $238–678B.

The problem

The same food does not produce the same result.

Nutrition is designed and sold by composition: grams, calories, ingredients. But the body responds to food as a signal, and the response depends on context: time of day, metabolic state, history. Large published studies have shown that people respond very differently to identical meals.

Noise makes it worse. Scattered snacks, irregular hours, stress and poor sleep create many small signals that keep the response below the threshold.

Example: the PREDICT study (Berry et al., Nature Medicine, 2020) documented large person-to-person differences in post-meal responses to identical meals.

The platform

BIOMIKS: designing food for the response.

Nutradina products are built on BIOMIKS, GiNOVA's formulation system. Food matrices are designed and sequenced to deliver one clean, coherent signal instead of noise, and every formula is mapped for viscosity, nutrient density and post-meal behavior. The system rests on a three-part research line.

Theory

The Metabolic Operating System (mOS)

Why identical inputs give different outcomes: nutrients evaluated as signals in context.

Prepared for Trends in Endocrinology & Metabolism
Method

Signal-Based Food Engineering

How to design products for defined responses: signal vocabulary, Synergistic Signal Index, matrix architecture.

Submitted to Journal of Food Science
Governance

When Food Claims Fail

When a functional claim can be defended: context, reliability across conditions, disclosed failure modes.

Ready for submission

Why now

Four forces are converging.

  • The science has matured

    Evidence on individual variability in food response is now published and widely discussed.

  • Claims are under scrutiny

    Regulators require substantiation (EU Reg. 1924/2006). Brands need claims that hold up, which is what our governance layer is built for.

  • Demand keeps growing

    Functional food is a large, expanding category, with industry estimates near $600B by 2033.

  • R&D can move faster

    GiNOVA's GATE Protocol applies structured, AI-assisted decision engineering to formulation and validation.

Business model

Validate in control, then scale.

Launch market: Italy, with EU expansion from there.

We start where the consumption protocol can be controlled and measured, and move to licensing and packaged products once the data supports it.

Phase 1

Controlled pilot

Formulas served under guided conditions in corporate and technopark settings. Sensory acceptance, adherence and repeat purchase measured.

Phase 2

B2B and licensing

The BIOMIKS formulation library and validation protocol offered to institutional kitchens, partners and manufacturers.

Phase 3

Branded lines

Nutradina consumer lines, and Xooform for animal metabolism, launched once the evidence supports each claim.

How we fund each stage

Capital that matches the stage.

We raise in the order the evidence earns it: early-stage and non-dilutive capital first, larger and strategic capital once the pilot has produced data.

Now · pre-launch

  • EU and Italian R&D programs
  • Angel networks and seed investors
  • Specialist food and nutrition funds

After the pilot

  • Strategic partners and corporate venture arms
  • Family offices and food-security funds, including the Gulf
  • Licensing partners for BIOMIKS formulations

At scale

  • Growth funds
  • Strategic rounds with industry leaders

Pipeline

13 projects, 7 families.

Five consumer lines lead. Three are announced; two remain under wraps until launch. Professional lines follow for clinical and institutional settings.

AnnouncedIn development or research

Performance

BIOFORCECOGNITA

Intense days

BioShield+1

Start of the day

2 projects

Specialized lines

3 projects

Inner ecology

2 projects

Rhythm and timing

2 projects

Professional settings

2 projects

Defensibility

What is hard to copy.

Ingredients can be copied. An integrated system of method, data and evidence cannot be copied quickly.

Formulation library

A growing database mapping matrix structure, nutrient density and post-meal response.

Validation protocol

Claim-safe evidence standards that build trust with institutions and partners.

Research base and method

The mOS theory, the signal-based engineering method and the GATE decision protocol, developed in-house.

Roadmap

Where we are.

  1. In progress

    Research

    Theory, method and governance papers prepared.

  2. Now

    Formulation

    First lines taking shape at GiNOVA Engineering.

  3. Next

    Pilot

    Controlled tastings, analytical testing, first partners.

  4. Coming

    Launch

    Lines released as each claim's evidence is in place.

The round size, use of funds and milestone plan are shared in the investor briefing.

Team

The people behind it.

Kunter İlalan

Founder · Managing Director, GiNOVA

Food engineer (BSc, METU). Fifteen years in the food industry and fifteen in information technology. Leads the signal-based nutrition program.

Prof. Dr. Fatih Yıldız

Research partner · METU

Professor of Biochemistry and Food Engineering; founding chair (retired) of METU's Department of Food Engineering. Co-author of the research program.

GiNOVA Academy

Domain experts

Specialists in the fields each line requires. Profiles are shared in the briefing.

How we engage investors

A clear, confidential process.

  1. Request

    Write to investors@nutradina.it with a short introduction.

  2. Intro call

    30 minutes with the founder.

  3. NDA

    A mutual confidentiality agreement.

  4. Data room

    Research, formulation plan, financial model and round terms.

  5. Deep-dive

    Sessions with the founder and GiNOVA Academy.

Early conversations shape the best partnerships.

Request the investor briefinginvestors@nutradina.it